1-tert-Butyl 3-methyl trans-5-aminopiperidine-1,3-dicarboxylate

Catalog No. :
ACUZSX382
CAS No. :
1208359-58-3
Molecular Formula :
C12H22N2O4
Molecular Weight :
258.32

IUPAC Name:1-(tert-butyl) 3-methyl (3R,5R)-5-aminopiperidine-1,3-dicarboxylate

1-tert-Butyl 3-methyl trans-5-aminopiperidine-1,3-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg94%$239.00Login to see priceIn stockInquiry
250mg94%$479.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-tert-Butyl 3-methyl trans-5-aminopiperidine-1,3-dicarboxylate
IUPAC Name1-(tert-butyl) 3-methyl (3R,5R)-5-aminopiperidine-1,3-dicarboxylate
MDL No.MFCD26516374
Molecular FormulaC12H22N2O4
Molecular Weight258.32
SMILESO=C(N1C[C@H](C(OC)=O)C[C@@H](N)C1)OC(C)(C)C
InChI KeyBEOGYMDIRWHZBM-RKDXNWHRSA-N
Synonym1-(tert-butyl) 3-methyl (3S,5S)-5-aminopiperidine-1,3-dicarboxylate;1-tert-butyl 3-methyl trans-5-aminopiperidine-1,3-dicarboxylate;rel-1-(1,1-Dimethylethyl) 3-methyl (3R,5R)-5-amino-1,3-piperidinedicarboxylate;Methyl trans-1-Boc-5-aminopiperidine-3-carboxylate
CAS No.1208359-58-3
PubChem CID59224138

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H315-H318-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P310-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACUZSX382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUZSX382 route product structure diagram
    ACUZSX3821208359-58-3 In Stock
Inquiry

2. ACUZSX382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUZSX382 route product structure diagram
    ACUZSX3821208359-58-3 In Stock
Inquiry

Comments (0)